Elasomeran, Imelasomeran

2 trials JAnti-infectives

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

2 Completed trials

3 Sponsors

2 Countries

Phase IV

Phase IV: 2

Indications tested

COVID-19 1 Influenza 1

Sponsors using this IMP

Finnish Institute For Health And Welfare 1 Gentofte Hospital 1 Sanofi Pasteur 1

All trials

2 total

A Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influe… Ended

2022-500657-17-00 Phase IV 1 country Gentofte Hospital; Sanofi Pasteur
COVID-19 vaccine immunology Ended

2024-517357-27-00 Phase IV 1 country Finnish Institute For Health And Welfare

Showing 1–2 of 2 trials

← All drugs A–Z